Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303.
      Google Scholar   
Citation:
J Geriatr Oncol vol 16 (2) 102185
Year:
2025
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Older Adult
Sec. Committees:
Lymphoma    
Pharmas:
 
Grants:
UG1CA189823, UG1 CA232760  
Corr. Author:
 
Authors:
             
Networks:
LAPS-MN026, METROMIN, NY018   
Study
Alliance-A151930
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-50303
Phases:
N/A, 3
Keywords: